0001130598-26-000004.txt : 20261105 0001130598-26-000004.hdr.sgml : 20261105 20261105141920 ACCESSION NUMBER: 0001130598-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261105 DATE AS OF CHANGE: 20261105 EFFECTIVENESS DATE: 20261105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Traws Pharma, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-603794 FILM NUMBER: 261526555 BUSINESS ADDRESS: STREET 1: 12 PENNS TRAIL CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3680 MAIL ADDRESS: STREET 1: 12 PENNS TRAIL CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: Onconova Therapeutics, Inc. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 D 1 primary_doc.xml X0708 D LIVE 0001130598 Traws Pharma, Inc. 12 PENNS TRAIL NEWTOWN PA PENNSYLVANIA 18940 267-759-3680 DELAWARE Onconova Therapeutics, Inc. ONCONOVA THERAPEUTICS, INC. ONCONOVA THERAPEUTICS INC Corporation true Iain Dukes 12 Penns Trail Newton PA PENNSYLVANIA 18940 Executive Officer Director CEO & Director Charles Parker 12 Penns Trail Newton PA PENNSYLVANIA 18940 Executive Officer CFO Jack E. Stover 12 Penns Trail Newtown PA PENNSYLVANIA 18940 Director Chair Nikolay Savchuk 12 Penns Trail Newtown PA PENNSYLVANIA 18940 Director Trafford Clarke 12 Penns Trail Newtown PA PENNSYLVANIA 18940 Director Mary Teresa Shoemaker 12 Penns Trail Newtown PA PENNSYLVANIA 18940 Director John Leaman 12 Penns Trail Newtown PA PENNSYLVANIA 18940 Director Werner Cautreels 12 Penns Trail Newtown PA PENNSYLVANIA 18940 Director Biotechnology Decline to Disclose 06b false true true true false 0 50000000 0 50000000 Offering is a committed equity facility under which the issuer has the right, in its sole discretion, to sell to the investor up to an aggregate of $50,000,000 of the issuer's common stock from time to time, subject to certain limitations. false 1 0 0 0 false Traws Pharma, Inc. Charles Parker Charles Parker CFO 2026-11-05